Based on NIH | Do smokers taking metformin have a higher risk of side effects, such as lactic acidosis, compared with non-smokers?

Overview

Based on available evidence, smoking itself does not appear to directly increase the risk of metformin-related side effects such as lactic acidosis compared with non‑smokers. Lactic acidosis with metformin is already rare, and the strongest, well‑established risk factors are kidney impairment, severe liver disease, heart failure, heavy alcohol use, acute illness causing poor oxygen delivery (like sepsis or shock), and advanced age not smoking per se. ^{[1] [2]}

That said, smoking can contribute to diseases (e.g., chronic obstructive pulmonary disease, cardiovascular disease) that may reduce oxygen delivery or worsen overall health, which could indirectly raise risk if those conditions become severe. This is more of an indirect pathway rather than a proven direct interaction between smoking and metformin. In routine practice, metformin is not contraindicated solely due to smoking. ^[2]

---

What we know about metformin and lactic acidosis

• Lactic acidosis is a very rare but serious complication of metformin, typically occurring when metformin levels become elevated and there is a second stressor that disrupts lactate handling (such as severe kidney failure, advanced liver disease, sepsis, or hypoperfusion). ^[2]
• Large pooled analyses of clinical trials and cohort studies found no increased incidence of lactic acidosis in metformin users compared to non‑users; the estimated upper bound of true incidence was fewer than about 5 cases per 100,000 patient‑years in both groups. This supports that metformin itself has a very low lactic acidosis risk when used appropriately. ^[1]
• Metformin is eliminated unchanged by the kidneys; dose and use should be aligned with kidney function because accumulation in renal impairment increases risk. Renal function is a central determinant of safety. ^{[3] [4]}

---

Established risk factors (not including smoking)

Regulators consistently highlight the following as known or possible risk factors for metformin‑associated lactic acidosis:

• Renal impairment (the most important risk factor; metformin is substantially excreted by the kidney). ^{[5] [4]}
• Liver problems and heart failure, especially in settings of hypoperfusion or hypoxemia. ^{[6] [7]}
• Heavy alcohol use (both chronic and binge patterns), which can raise lactate. ^{[8] [9]}
• Advanced age (particularly over 80, when kidney function must be confirmed as normal). ^[6]
• Serious dehydration, severe infection, or procedures using iodinated contrast without appropriate holds and renal checks. ^[7]

None of these official safety communications list smoking alone as a specific risk factor for metformin‑associated lactic acidosis. This indicates that smoking, by itself, is not recognized as an independent risk criterion in metformin labeling. ^{[6] [7]}

---

Could smoking indirectly matter?

• Smoking increases risks for chronic lung disease and cardiovascular disease, which in advanced forms can lead to hypoxemia (low oxygen) or hypoperfusion (poor blood flow). Those states are among the conditions that can precipitate lactic acidosis when combined with elevated metformin levels. ^[2]
• Therefore, while smoking itself is not a listed risk, severe smoking‑related complications might contribute to overall risk in a complex clinical scenario. This would be indirect and condition‑dependent. ^[2]

---

Metformin pharmacokinetics and the role of kidneys

• Metformin’s clearance tracks with creatinine clearance; as kidney function declines, metformin exposure increases, which raises the chance of adverse effects. Dosing should be adjusted accordingly. ^[3]
• The mean elimination half‑life is about 5 hours in those with normal kidney function; keeping average plasma concentrations below about 2.5 mg/L has been suggested to minimize risk of lactic acidosis. Kidney health and proper dosing are key safety levers. ^[3]

---

Practical guidance for smokers using metformin

• Smoking cessation is strongly beneficial for overall health, glycemic control, and cardiovascular risk, but stopping smoking is not a formal requirement to use metformin safely.
• Focus on modifiable, proven risk factors:
  • Keep alcohol intake low; avoid binge drinking. Alcohol increases lactic acidosis risk. ^{[8] [9]}
  • Ensure kidney function is checked regularly and dosing is adjusted if eGFR declines. This is the most important safety step. ^[4]
  • Inform your clinician about any liver disease, heart failure, severe infections, dehydration, or plans for iodinated contrast imaging. Temporary drug holds may be needed. ^[7]
• Be aware of lactic acidosis symptoms (though rare): unusual fatigue, muscle pain, trouble breathing, stomach discomfort, dizziness, or slow/irregular heartbeat; seek urgent care if these occur, especially during acute illness. Prompt evaluation matters because lactic acidosis can be serious. ^{[9] [10]}

---

Bottom line

• Current data do not show that smokers on metformin have a higher direct risk of lactic acidosis compared with non‑smokers. The key determinants of risk are kidney function, heavy alcohol use, severe acute illness, and advanced organ disease. ^{[1] [2] [4]}
• Smoking may indirectly increase risk only if it leads to severe cardiopulmonary disease with hypoxemia or hypoperfusion, which are recognized contexts for lactic acidosis in general. In the absence of such complications, metformin use in smokers follows the same safety principles as in non‑smokers. ^[2]

Would you like help reviewing your kidney function results or other conditions to personalize your metformin safety plan?